Financials
Financial year 2025
Gross margin
€ -1,127
▼ 130% vs 2024
Profit
Caution€ -1,347
▼ 138% vs 2024
Debts
Normal€ 11,654
▲ 382% vs 2024
EB Pharma Developments from Alken, company number BE0780755671, closed financial year 2025 with a result of € -1,347 after tax. For that financial year EB Pharma Developments recorded a gross margin of € -1,127 and equity of € 5,298. Compared with financial year 2024, the result moved from € 3,567 to € -1,347. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 25, 2026.
What happened at EB Pharma Developments?
What happened at EB Pharma Developments in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1,347 (▼ 138% vs 2024). Source: NBB ↗
- New establishment in Alken. KBO
- Start of the company according to the CBE. KBO
- ERIK BUNTINX became a director. NBB
In short
From € 16,222 profit in 2022 to € 1,347 loss in 2025.
Paid € 4,316 in corporate taxes since 2022.
Best year ever: 2022, with € 16,222 profit.
Paid out € 10,000 in dividends to the owners in total.
A new publication or filing at EB Pharma Developments? We notify you, reason included.
Follow EB Pharma DevelopmentsNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind EB Pharma Developments is ERIK BUNTINX. ERIK BUNTINX is also behind B & B BEHEER, ANIMA, INTEGRA INVEST Alken, Elise Buntinx and LINDE BUNTINX.
Directors
According to the 2025 annual accounts
since 2022
Establishments
Establishment units
Physical locations of this company
Alkerstraat 28
3570 Alken
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Domain
Domain
animaresearch.com
Registered
2019-01-11
Registrar
Realtime Register B.V.
Expires
2027-01-11
Website info
Features
Security
Details
- Company number
- 0780.755.671
- VAT number
- BE 0780.755.671
- Registered office
- Alkerstraat 28, 3570 Alken
- Names & denominations
- EB Pharma Developments
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 21 January 2022
- Peppol
- Active · Active since 23 Apr 2026
- Contact
- animaresearch.com
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied